2015
What is the role of dosimetry in patients with advanced thyroid cancer?
Chen MK, Cheng DW. What is the role of dosimetry in patients with advanced thyroid cancer? Current Opinion In Oncology 2015, 27: 33-37. PMID: 25319079, DOI: 10.1097/cco.0000000000000145.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPositron emission tomography-computed tomographyThyroid cancerLesional dosimetryPretreatment dosimetryAdvanced differentiated thyroid cancerEmission tomography-computed tomographyIntermediate-risk patientsAdvanced thyroid cancerMetastatic thyroid cancerDifferentiated thyroid cancerTomography-computed tomographyRenal insufficiencyElderly patientsRenal failureRisk patientsProlonged withdrawalPatientsHigh dosesThyroid hormonesSimilar outcomesTreatment dosageCancerRole of dosimetryUptake of iodineWhole body
2010
Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
Chen MK, Doddamane I, Cheng DW. Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management. Current Opinion In Oncology 2010, 22: 6-10. PMID: 19844179, DOI: 10.1097/cco.0b013e3283339d5d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRecombinant human thyroid-stimulating hormoneHuman thyroid-stimulating hormoneMetastatic thyroid cancerThyroid-stimulating hormoneThyroid cancerThyroglobulin levelsWhole body radiation exposureThyroid hormone withdrawalThyroid remnant ablationFurther prospective studiesLong-term outcomesRate of recurrenceSurveillance of patientsThyroid cancer managementBody radiation exposureNegative predictive valueRadioiodine ablationPersistent diseaseRadioiodine treatmentRemnant ablationThyroid remnantsWithdrawal patientsPatients' qualityPatient groupProspective study